These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7625095)

  • 21. BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis.
    Rolin S; Petein M; Tchana-Sato V; Dogne JM; Benoit P; Lambermont B; Ghuysen A; Kolh P; Masereel B
    J Pharmacol Exp Ther; 2003 Jul; 306(1):59-65. PubMed ID: 12721335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosing frequency of aspirin and prevention of heart attacks and strokes.
    Amory JK; Amory DW
    Am J Med; 2007 Apr; 120(4):e5; author reply e7. PubMed ID: 17398214
    [No Abstract]   [Full Text] [Related]  

  • 23. Why a little aspirin is better than a lot.
    Merz B
    JAMA; 1987 Apr; 257(16):2135. PubMed ID: 3550164
    [No Abstract]   [Full Text] [Related]  

  • 24. Aspirin and warfarin versus aspirin monotherapy after myocardial infarction.
    Jeddy AS; Gleason BL
    Ann Pharmacother; 2003 Oct; 37(10):1502-5. PubMed ID: 14519047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stretch-induced contraction of rabbit isolated pulmonary artery and the involvement of endothelium-derived thromboxane A2.
    Nakayama K; Ueta K; Tanaka Y; Tanabe Y; Ishii K
    Br J Pharmacol; 1997 Sep; 122(2):199-208. PubMed ID: 9313926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of acetylsalicylic acid in IHD].
    Lenkovsky F; Neirinck LG; Glezer SV
    Ter Arkh; 1996; 68(8):79-83. PubMed ID: 9019841
    [No Abstract]   [Full Text] [Related]  

  • 27. [Response to the letter by W. Förster on: prevention of reinfarction with 100 mg or 30 mg aspirin daily].
    Schrör K
    Z Kardiol; 1996 May; 85(5):357. PubMed ID: 8711949
    [No Abstract]   [Full Text] [Related]  

  • 28. [The mechanisms of the hereditary predisposition to ischemic heart disease].
    Tseluĭko VI; Kantimir EV; Kostiurina GI; Bogmat LF
    Tsitol Genet; 1993; 27(4):77-81. PubMed ID: 8249169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development.
    Patrono C; Patrignani P; Rocca B; Landolfi R
    Thromb Haemost; 1995 Jul; 74(1):396-400. PubMed ID: 8578493
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin for heart patients.
    FDA Drug Bull; 1985 Dec; 15(4):34-6. PubMed ID: 4092900
    [No Abstract]   [Full Text] [Related]  

  • 33. [Low-dose ASA and infarct prophylaxis. Acetylsalicylic acid (ASA): low doses with high efficiency].
    Internist (Berl); 1995 Jan; 36(1 Suppl Low-dose-a):1-4. PubMed ID: 9431355
    [No Abstract]   [Full Text] [Related]  

  • 34. [Protective effects and mechanism of action of aspirin on focal cerebral ischemia-reperfusion in rats].
    Qiu LY; Yu J; Zhou Y; Chen CH
    Yao Xue Xue Bao; 2003 Aug; 38(8):561-4. PubMed ID: 14628442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin.
    Yamamoto T; Cohen AM; Kakar NR; Yamamoto M; Johnson PE; Cho YK; Bing RJ
    Biochem Biophys Res Commun; 1999 Apr; 257(2):488-93. PubMed ID: 10198239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 37. President lecture. Acute myocardial infarction: current status and prospective view.
    Kawai C
    Jpn Circ J; 1987 Jan; 51(1):5-14. PubMed ID: 3295319
    [No Abstract]   [Full Text] [Related]  

  • 38. Ask about aspirin.
    Peota C
    Minn Med; 2015 Aug; 98(8):8. PubMed ID: 26455029
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin for prevention of myocardial infarction. A double-edged sword.
    Bar-Dayan Y; Levy Y; Amital H; Shoenfeld Y
    Ann Med Interne (Paris); 1997; 148(6):430-3. PubMed ID: 9538376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Coronary disease: benefits of aspirin. What dose for which disease?].
    Michel PL
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):204-10. PubMed ID: 8024235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.